Yong Zu Kim
Director
chemistry
legochembio
Korea
Biography
Career & Research Projects - Director, LG Biomedical Institute, San Diego, U.S. - Director, LG New Drug Research Center - “FACTIVE” (quinolone antibiotics): the first US FDA approved new drug developed in Korea - Government Industry Award for global out-licensing deal to Glaxo Education - B.A. in Chemistry, Seoul National University - M.A & Ph.D in Organic Chemistry, KAIST
Research Interest
chemistry
